RT-3

RETATRUTIDE (RT)

Retatrutide (LY3437943) is an investigational triple-receptor agonist being studied for activity at the GIP, GLP-1, and glucagon receptors.

Research has investigated retatrutide for body-weight reduction and fat-loss-related outcomes, along with metabolic health and glucose regulation. Clinical research has demonstrated substantial reductions in body weight in adults with obesity.

Product Details

• Retatrutide (RT)

• LY3437943

• GIP / GLP-1 / Glucagon receptor activity

• Investigational research compound

• Fat-loss & metabolic research

SIMPLY SUPPLIES

PURE. RELIABLE. RESULTS.

Simply Better.